Commentary on the real-world effectiveness of vedolizumab in therapy-experienced ulcerative colitis: A response to Azzam et al.

Commentary on the real-world effectiveness of vedolizumab in therapy-experienced ulcerative colitis: A response to Azzam et al.

Saved in:

Bibliographic Details
Main Authors:	Turki A. Alameel, Howra W. Alhashim
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-03-01
Series:	The Saudi Journal of Gastroenterology
Online Access:	https://journals.lww.com/10.4103/sjg.sjg_27_25
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study
by: Kei Nomura, et al.
Published: (2024-09-01)

The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group
by: Nahla Azzam, et al.
Published: (2025-01-01)

Vedolizumab–steroid combination therapy improves long-term prognosis in patients with ulcerative colitis
by: Yosuke Yamada, et al.
Published: (2025-04-01)

Efficacy and safety of vedolizumab in elderly and younger patients with moderate-to-severe ulcerative colitis: a retrospective real-world study in China
by: Hao Zhang, et al.
Published: (2025-07-01)

Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
by: Hironobu Takedomi, et al.
Published: (2025-01-01)

A systematic review of vedolizumab in treating pediatric ulcerative colitis: efficacy and safety insights
by: Khawla Abu Hammour, et al.
Published: (2025-07-01)

Efficacy and Safety of Vedolizumab with Glucocorticoids vs Infliximabin Severe Ulcerative Colitis: A Retrospective Study
by: Zhang C, et al.
Published: (2025-06-01)

Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: a real-world cohort study
by: Horng-Yih Chiu, et al.
Published: (2024-12-01)

The systemic immune-inflammation index is superior to predicting clinical remission and relapse for ulcerative colitis patients treated with vedolizumab
by: Jing Yan, et al.
Published: (2025-03-01)

Anaphylaxis to a Vedolizumab Infusion following Drug Holiday in a Patient with Ulcerative Colitis: A Case Report
by: Jadon Karp, et al.
Published: (2025-02-01)

Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects
by: Yibing Hu, et al.
Published: (2024-12-01)

Predictive Value of Albumin to Fibrinogen Ratio and CALLY Index for Diagnosis of Ulcerative Colitis and Mucosal Healing After Vedolizumab Treatment
by: Su K, et al.
Published: (2025-01-01)

Association between vedolizumab and risk of clostridium difficile infection in patients with ulcerative colitis: A systematic review and meta-analysis
by: Maha Alghamdi, et al.
Published: (2024-11-01)

Colonic Lung Cancer Metastasis in Vedolizumab-Treated Immune Checkpoint Inhibitor Colitis
by: Sean S. Davis, et al.
Published: (2020-07-01)

Use of corticosteroids for remission induction therapy in patients with new-onset ulcerative colitis in real-world settings
by: Motohiro Okayasu, et al.
Published: (2019-01-01)

Spontaneous Urethral Laceration in a Patient Experiencing Acute Ulcerative Colitis Flare
by: Ryan Morris, et al.
Published: (2020-01-01)

Vedolizumab en tratamiento de colitis ulcerativa refractaria asociada con psoriasis: reporte de caso
by: Gabriel Alonso Mosquera-Klinger, et al.
Published: (2019-04-01)

Ustekinumab and Vedolizumab Dual Biologic Therapy in the Treatment of Crohn’s Disease
by: Eddie Y. Liu, et al.
Published: (2017-01-01)

Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres
by: David Young, et al.
Published: (2025-01-01)

Budesonide Enemas for Topical Therapy of Ulcerative Colitis
by: P Rutgeerts
Published: (1990-01-01)

Effective domestic mesalazine in the therapy of ulcerative colitis
by: I. N. Ruchkina, et al.
Published: (2021-06-01)

Progressing or preserving, disease extent evolution in hospitalized patients with ulcerative colitis in China: a real-world study
by: Yinghao Sun, et al.
Published: (2025-06-01)

Vedolizumab for inflammatory bowel diseasesI
by: Igor L. Khalif, et al.
Published: (2018-08-01)

Unmet needs in adult patients with ulcerative colitis in Spain: a real-world Adelphi Disease Specific Programme study
by: Ignacio Marín-Jiménez, et al.
Published: (2025-03-01)

Ulcerative Colitis: Therapy or Disease Association with Cancer Development
by: Cassidy Eby, et al.
Published: (2025-06-01)

Safety of full bowel preparation and colonoscopy in elderly patients with ulcerative colitis: A real‐world multicenter retrospective cohort study
by: Yu Hashimoto, et al.
Published: (2024-04-01)

Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
by: A. Yu. Baranovsky, et al.
Published: (2012-06-01)

Anaemia in Patients with Ulcerative Colitis: Risk Factors and Therapy Optimization
by: T. Ye. Chernyshova, et al.
Published: (2024-11-01)

Curcumin as a Novel Trend in Adjunctive Therapy for Ulcerative Colitis
by: Anatoly I. Khavkin, et al.
Published: (2024-12-01)

Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis
by: Arisa Fukuyama, et al.
Published: (2024-10-01)

Impact of completely histological remission on reducing flare-ups in moderate-to-severe, biologics-experienced ulcerative colitis patients with endoscopic remission
by: Zih-Hao Wei, et al.
Published: (2025-08-01)

Segmental colitis associated with diverticulosis: Progress to ulcerative colitis
by: Akira Hokama
Published: (2025-04-01)

COMORBIDITIES IN PATIENTS WITH ULCERATIVE COLITIS
by: T. E. Chernyshova, et al.
Published: (2020-11-01)

Unusual Manifestation of Ulcerative Colitis
by: Amna Basheer M. Ahmed, et al.
Published: (2019-01-01)

Updated Management of Ulcerative Colitis
by: Muhamad Reza Prabowo, et al.
Published: (2025-08-01)

Maintaining Remission in Distal Ulcerative Colitis and Ulcerative Proctitis
by: PB Miner, et al.
Published: (1990-01-01)

Effect of local ozone therapy on inflammatory markers in experimental ulcerative colitis
by: E. V. Davydova, et al.
Published: (2022-04-01)

Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy
by: George Chigozie Njoku, et al.
Published: (2025-03-01)

Treatment-refractory ulcerative colitis responsive to indigo naturalis
by: Berkeley Limketkai, et al.
Published: (2021-10-01)

Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis
by: Candace L. Beilman, et al.
Published: (2016-01-01)